Potential salivary proteomic markers of oral squamous cell carcinoma

Cancer Genomics and Proteomics

Volumn 13, Issue 1, 2016, Pages 55-62

  Gallo, Crescenzio ^a   Ciavarella, Domenico ^a   Santarelli, Andrea ^b   Ranieri, Elena ^a   Colella, Giuseppe ^c   Muzio, Lorenzo Lo ^a   Russo, Lucio Lo ^a  

^a UNIVERSITY OF FOGGIA   (Italy)

^b UNIVERSITÀ POLITECNICA DELLE MARCHE   (Italy)

^c SECOND UNIVERSITY OF NAPLES   (Italy)

Author keywords

Biomarkers; Oral cancer; Proteomic; Saliva; SELDI TOF

Indexed keywords

PROTEOME; TUMOR MARKER;

ACCURACY; ADULT; AGED; ARTICLE; ARTIFICIAL NEURAL NETWORK; CANCER PATIENT; CANCER PROGNOSIS; CARCINOGENESIS; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; LYMPH NODE METASTASIS; MALE; MOUTH SQUAMOUS CELL CARCINOMA; PROTEIN EXPRESSION; PROTEOMICS; SALIVA ANALYSIS; SURFACE ENHANCED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; CARCINOMA, SQUAMOUS CELL; CASE CONTROL STUDY; CHEMISTRY; HEAD AND NECK NEOPLASMS; MATRIX-ASSISTED LASER DESORPTION-IONIZATION MASS SPECTROMETRY; METABOLISM; MIDDLE AGED; MOUTH NEOPLASMS; PROGNOSIS; SALIVA; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; BIOMARKERS, TUMOR; CARCINOMA, SQUAMOUS CELL; CASE-CONTROL STUDIES; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; MALE; MIDDLE AGED; MOUTH NEOPLASMS; PROGNOSIS; SALIVA; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION;

EID: 84959340366     PISSN: 11096535     EISSN: 17906245     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Engwegen JY, Helgason HH, Cats A, Harris N, Bonfrer JM, Schellens JH and Beijnen JH: Identification of serum proteins discriminating colorectal cancer patients and healthy controls using surface-enhanced laser desorption ionisation-time of flight mass spectrometry. World J Gastroenterol 12:1536-1544, 2006.
2. Fabian TK, Fejerdy P and Csermely P: Salivary Genomics, Transcriptomics and Proteomics: The Emerging Concept of the Oral Ecosystem and their Use in the Early Diagnosis of Cancer and other Diseases. Curr Genomics 9:11-21, 2008.
3. Fredolini C, Liotta LA and Petricoin EF: Application of proteomic technologies for prostate cancer detection, prognosis, and tailored therapy. Crit Rev Clin Lab Sci 47:125-138, 2010.
4. Freed GL, Cazares LH, Fichandler CE, Fuller TW, Sawyer CA, Stack BC, Jr., Schraff S, Semmes OJ, Wadsworth JT and Drake RR: Differential capture of serum proteins for expression profiling and biomarker discovery in pre- and posttreatment head and neck cancer samples. Laryngoscope 118:61-68, 2008.
5. Freeman JA and Skapura DM: Algorithms, Applications, and Programming Techniques. USA: Addison-Wesley Publishing Company, 1991.
6. Gast MC, Schellens JH and Beijnen JH: Clinical proteomics in breast cancer: a review. Breast Cancer Res Treat 116:17-29, 2009.
7. Giusti L, Baldini C, Bazzichi L, Ciregia F, Tonazzini I, Mascia G, Giannaccini G, Bombardieri S and Lucacchini A: Proteome analysis of whole saliva: a new tool for rheumatic diseases - the example of Sjogren's syndrome. Proteomics 7:1634-1643, 2007.
8. Gourin CG, Xia ZS, Han Y, French AM, O'Rourke AK, Terris DJ and Adam BL: Serum protein profile analysis in patients with head and neck squamous cell carcinoma. Arch Otolaryngol Head Neck Surg 132:390-397, 2006.
9. Gourin CG, Zhi W and Adam BL: Proteomic identification of serum biomarkers for head and neck cancer surveillance. Laryngoscope 119:1291-1302, 2009.
10. He H, Sun G, Ping F and Cong Y: A new and preliminary three-dimensional perspective: proteomes of optimization between OSCC and OLK. Artif Cells Blood Substit Immobil Biotechnol 39:26-30, 2011.
11. He J, Gornbein J, Shen D, Lu M, Rovai LE, Shau H, Katz J, Whitelegge JP, Faull KF and Chang HR: Detection of breast cancer biomarkers in nipple aspirate fluid by SELDI-TOF and their identification by combined liquid chromatography-tandem mass spectrometry. Int J Oncol 30:145-154, 2007.
12. Hu S, Arellano M, Boontheung P, Wang J, Zhou H, Jiang J, Elashoff D, Wei R, Loo JA and Wong DT: Salivary proteomics for oral cancer biomarker discovery. Clin Cancer Res 14:6246-6252, 2008.
13. Hu S, Loo JA and Wong DT: Human saliva proteome analysis. Ann NY Acad Sci 1098:323-329, 2007.
14. Hu S, Yu T, Xie Y, Yang Y, Li Y, Zhou X, Tsung S, Loo RR, Loo JR and Wong DT: Discovery of oral fluid biomarkers for human oral cancer by mass spectrometry. Cancer Genomics Proteomics 4:55-64, 2007.
15. Issaq HJ, Veenstra TD, Conrads TP and Felschow D: The SELDI-TOF MS approach to proteomics: protein profiling and biomarker identification. Biochem Biophys Res Commun 292:587-592, 2002.
16. Jemal A, Bray F, Center MM, Ferlay J, Ward E and Forman D: Global cancer statistics. CA Cancer J Clin 61:69-90, 2011.
17. Jemal A, Siegel R, Ward E, Murray T, Xu J and Thun MJ: Cancer statistics, 2007. CA Cancer J Clin 57:43-66, 2007.
18. Lee JM and Kohn EC: Proteomics as a guiding tool for more effective personalized therapy. Ann Oncol 21(Suppl 7):vii205-vii210, 2010.
19. Lo Russo L, Papale M, Perrone D, Ranieri E, Rubini C, Giannatempo G, Santarelli A, Colella G and L. LM: Salivary proteomic signatures of oral squamous cell carcinoma. European Journal of Inflammation 10:61-70, 2012.
20. McGurk M, Chan C, Jones J, O'Regan E and Sherriff M: Delay in diagnosis and its effect on outcome in head and neck cancer. Br J Oral Maxillofac Surg 43:281-284, 2005.
21. Miller CS, Foley JD, Bailey AL, Campell CL, Humphries RL, Christodoulides N, Floriano PN, Simmons G, Bhagwandin B, Jacobson JW, Redding SW, Ebersole JL and McDevitt JT: Current developments in salivary diagnostics. Biomark Med 4:171-189, 2010.
22. Nagler RM: Saliva as a tool for oral cancer diagnosis and prognosis. Oral Oncol 45:1006-1010, 2009.
23. Papale M, Pedicillo MC, Di Paolo S, Thatcher BJ, Lo Muzio L, Bufo P, Rocchetti MT, Centra M, Ranieri E and Gesualdo L: Saliva analysis by surface-enhanced laser desorption/ionization time-of-flight mass spectrometry (SELDI-TOF/MS): from sample collection to data analysis. Clin Chem Lab Med 46:89-99, 2008.
24. Petersen P: The World Oral Health Report 2003: continuous improvement of oral health in the 21st century - the approach of the WHO Global Oral Health Programme; Community dentistry and oral epidemiology. 3-23, 2003.
25. Scarlett CJ, Saxby AJ, Nielsen A, Bell C, Samra JS, Hugh T, Baxter RC and Smith RC: Proteomic profiling of cholangiocarcinoma: diagnostic potential of SELDI-TOF MS in malignant bile duct stricture. Hepatology 44:658-666, 2006.
26. Seoane Leston J and Diz Dios P: Diagnostic clinical aids in oral cancer. Oral Oncol 46:418-422, 2010.
27. Shintani S, Hamakawa H, Ueyama Y, Hatori M and Toyoshima T: Identification of a truncated cystatin SA-I as a saliva biomarker for oral squamous cell carcinoma using the SELDI ProteinChip platform. Int J Oral Maxillofac Surg 39:68-74, 2010.
28. Sobin LH and Wittekind CH: International union against cancer (UICC): TNM classification of malignant tumors. New York: Wiley, 2002.
29. Soltys SG, Le QT, Shi G, Tibshirani R, Giaccia AJ and Koong AC: The use of plasma surface-enhanced laser desorption/ionization time-of-flight mass spectrometry proteomic patterns for detection of head and neck squamous cell cancers. Clin Cancer Res 10:4806-4812, 2004.
30. Wadsworth JT, Somers KD, Stack BC Jr., Cazares L, Malik G, Adam BL, Wright GL Jr. and Semmes OJ: Identification of patients with head and neck cancer using serum protein profiles. Arch Otolaryngol Head Neck Surg 130:98-104, 2004.